Abalone Bio (Seed+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$40,000,000
Company Info
Founders
Richard Yu
Market
Healthcare & Wellness
Coinvestors
BoxOne Ventures,OMX Ventures,Y Combinator
Company Description

A hybrid biological-computational platform to discover antibody drugs for the world's most difficult diseases. Abalone Bio develops full-spectrum antibody drugs to access promising therapeutic targets and unlock new disease treatments.